OpenURL Connection Search

Select item for more details and to access through your institution.

UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.94_2880
By:
- Búa, B. Rey;
- Jiménez‐Ubieto, A.;
- Blanco, J. J. Sánchez;
- Abrisqueta, P.;
- Gutiérrez, A.;
- Ramírez‐Páyer, Án.;
- Giné, E.;
- Etxetxipia, I. Zeberio;
- Terol, M. José;
- Cruz, F. de la;
- Andreu, R.;
- Ramírez, M.;
- Fuente, A. de la;
- Viguria, M.;
- Peñarrubia, M.;
- Grande, C.;
- Montes‐Moreno, S.;
- Barrigón, M. D. Caballero;
- García‐Sancho, A. Martín
Publication type:
Article
CURRENT ROLE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN MANTLE CELL LYMPHOMA IN THE ERA OF NEW IMMUNOTHERAPEUTIC AND TARGETED THERAPIES. THE GETH/GELTAMO EXPERIENCE.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.56_2880
By:
- Gutierrez, A.;
- Bento, L.;
- Novelli, S.;
- Gutierrez, G.;
- Salas, Q.;
- Bastos‐Oreiro, M.;
- Perez, A.;
- Hernani, R.;
- Viguria, M. C.;
- Lopez‐Godino, O.;
- Montoro, J.;
- Piñana, J. L.;
- Ferra, C.;
- Parody, R.;
- Martin, C.;
- Gomez‐Espuch, J.;
- Yañez, L.;
- Rodriguez, G.;
- Zanabilli, J.;
- Herrera, P.
Publication type:
Article
CHARACTERIZATION OF THE ONCOGENIC PHENOTYPE IN EXTRANODAL NATURAL KILLER/T‐CELL LYMPHOMA, NASAL TYPE THROUGH GENE EXPRESSION PROFILE. SPANISH LYMPHOMA GROUP GELTAMO.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.139_2880
By:
- González-Barca, E;
- Gato, L;
- Esteve, A;
- Sanz‐Pamplona, R;
- Tomás, L;
- Rodriguez, M;
- Martín García‐Sancho, A;
- Córdoba, R;
- Monter, A;
- Bastos, M;
- Bergua Burgues, J. M;
- Sayas, M. J;
- Viguria Alegria, M. C;
- Sánchez Blanco, J. J;
- Roig, M;
- Luzardo Henriquez, H. D;
- Oña, R;
- Cabezudo, E;
- Infante, M. S;
- Queizan, J. A
Publication type:
Article
Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC.
Published in:
Acta Haematologica, 2023, v. 146, n. 2, p. 161, doi. 10.1159/000528242
By:
- Velao, Sara Redondo;
- Garcia Cadenas, Irene;
- Cuesta, Mª Angeles;
- Sanchez-Ortega, Isabel;
- Fernández-Avilés, Francesc;
- Roldan, Elisa;
- Torrent, Anna;
- Viguria, M. Cruz;
- Villar, Sara;
- Bento, Leyre;
- Yáñez, Lucrecia;
- Martino, Rodrigo;
- Piñana, Jose Luis
Publication type:
Article

Found: 4

UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.

CURRENT ROLE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN MANTLE CELL LYMPHOMA IN THE ERA OF NEW IMMUNOTHERAPEUTIC AND TARGETED THERAPIES. THE GETH/GELTAMO EXPERIENCE.

CHARACTERIZATION OF THE ONCOGENIC PHENOTYPE IN EXTRANODAL NATURAL KILLER/T‐CELL LYMPHOMA, NASAL TYPE THROUGH GENE EXPRESSION PROFILE. SPANISH LYMPHOMA GROUP GELTAMO.

Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC.